Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years
- Resource Type
- Article
- Source
- In
Leukemia Research 2008 32(12):1800-1808 - Subject
- Language
- ISSN
- 0145-2126